A Hexane Fraction of Guava Leaves (Psidium guajavaL.) Induces Anticancer Activity by Suppressing AKT/Mammalian Target of Rapamycin/Ribosomal p70 S6 Kinase in Human Prostate Cancer Cells
- 1 March 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Medicinal Food
- Vol. 15 (3), 231-241
- https://doi.org/10.1089/jmf.2011.1701
Abstract
This study was carried out to evaluate the anticancer effects of guava leaf extracts and its fractions. The chemical compositions of the active extracts were also determined. In the present study, we set out to determine whether the anticancer effects of guava leaves are linked with their ability to suppress constitutive AKT/mammalian target of rapamycin (mTOR)/ribosomal p70 S6 kinase (S6K1) and mitogen-activated protein kinase (MAPK) activation pathways in human prostate cancer cells. We found that guava leaf hexane fraction (GHF) was the most potent inducer of cytotoxic and apoptotic effects in PC-3 cells. The molecular mechanism or mechanisms of GHF apoptotic potential were correlated with the suppression of AKT/mTOR/S6K1 and MAPK signaling pathways. This effect of GHF correlated with down-regulation of various proteins that mediate cell proliferation, cell survival, metastasis, and angiogenesis. Analysis of GHF by gas chromatography and gas chromatography–mass spectrometry tentatively identified 60 compounds, including β-eudesmol (11.98%), α-copaene (7.97%), phytol (7.95%), α-patchoulene (3.76%), β-caryophyllene oxide (CPO) (3.63%), caryophylla-3(15),7(14)-dien-6-ol (2.68%), (E)-methyl isoeugenol (1.90%), α-terpineol (1.76%), and octadecane (1.23%). Besides GHF, CPO, but not phytol, also inhibited the AKT/mTOR/S6K1 signaling pathway and induced apoptosis in prostate cancer cells. Overall, these findings suggest that guava leaves can interfere with multiple signaling cascades linked with tumorigenesis and provide a source of potential therapeutic compounds for both the prevention and treatment of cancer.Keywords
This publication has 63 references indexed in Scilit:
- Action Mechanism and Signal Pathways ofPsidium guajavaL. Aqueous Extract in Killing Prostate Cancer LNCaP CellsNutrition and Cancer, 2010
- Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extractNutrition & Metabolism, 2010
- Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumoursBritish Journal of Cancer, 2009
- International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta‐analysis of 1446 patientsBJU International, 2007
- Guaijaverin – a plant flavonoid as potential antiplaque agent against Streptococcus mutansJournal of Applied Microbiology, 2006
- MAMMALIAN TARGET OF RAPAMYCIN AND 3-PHOSPHATIDYLINOSITOL 3-KINASE PATHWAY INHIBITION ENHANCES GROWTH INHIBITION OF TRANSFORMING GROWTH FACTOR-β1 IN PROSTATE CANCER CELLSJournal of Urology, 2004
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapyNature, 2004
- Volatile Components and Aroma Active Compounds in Aqueous Essence and Fresh Pink Guava Fruit Puree (Psidium guajava L.) by GC-MS and Multidimensional GC/GC-OJournal of Agricultural and Food Chemistry, 2003
- Tannins and Related Compounds. CXVI. Six New Complex Tannins, Guajavins, Psidinins and Psiguavin from the Bark of Psidium guajava L.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990